Angels Almenar-Queralt

Angels Almenar-Queralt

Auto-generated profile, based on publicly available information

Angels Almenar-Queralt

UC San Diego

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2016 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MPMatthew L. Pearn
Matthew L. Pearn
INIngrid R. Niesman
Ingrid R. Niesman
JEJunji Egawa
Junji Egawa
ASAtsushi Sawada
Atsushi Sawada
AAAngels Almenar-Queralt
Angels Almenar-Queralt
BHBrian Head
Brian Head

18 November 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AAAngels Almenar-Queralt
Angels Almenar-Queralt
DMDaria Merkurjev
Daria Merkurjev
HKHong Sook Kim
Hong Sook Kim
MNMichael Navarro
Michael Navarro
QMQi Ma
Qi Ma
IGIvan Garcia-Bassets
Ivan Garcia-Bassets

1 December 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AAAngels Almenar-Queralt
Angels Almenar-Queralt
SKSonia N. Kim
Sonia N. Kim
CBChristopher Benner
Christopher Benner
CHCheryl M. Herrera
Cheryl M. Herrera
DKDavid E. Kang
David E. Kang
LGLawrence S. B. Goldstein
Lawrence S. B. Goldstein
Presenilins, the catalytic components of the γ-secretase complex, are upstream regulators of multiple cellular pathways via regulation of gene transcription. However, the underlying mechanisms and the genes regulated by these pathways are poorly characterized. In this study, we identify Tequila and its mammalian ortholog Prss12 as genes negatively regulated by presenilins in Drosophila larval brains and mouse embryonic fibroblasts, respectively. Prss12 encodes the serine protease neurotrypsin, which cleaves the heparan sulfate proteoglycan agrin. Altered neurotrypsin activity causes serious synaptic and cognitive defects; despite this, the molecular processes regulating neurotrypsin expression and activity are poorly understood. Using γ-secretase drug inhibitors and presenilin mutants in mouse embryonic fibroblasts, we found that a mature γ-secretase complex was required to repress neurotrypsin expression and agrin cleavage. We also determined that PSEN1 endoproteolysis or processing of well known γ-secretase substrates was not essential for this process. At the transcriptional level, PSEN1/2 removal induced cyclic AMP response element-binding protein (CREB)/CREB-binding protein binding, accumulation of activating histone marks at the neurotrypsin promoter, and neurotrypsin transcriptional and functional up-regulation that was dependent on GSK3 activity. Upon PSEN1/2 reintroduction, this active epigenetic state was replaced by a methyl CpG-binding protein 2 (MeCP2)-containing repressive state and reduced neurotrypsin expression. Genome-wide analysis revealed hundreds of other mouse promoters in which CREB binding is similarly modulated by the presence/absence of presenilins. Our study thus identifies Tequila and neurotrypsin as new genes repressed by presenilins and reveals a novel mechanism used by presenilins to modulate CREB signaling based on controlling CREB recruitment.

17 January 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RKRhiannon L. Killian
Rhiannon L. Killian
JFJessica D. Flippin
Jessica D. Flippin
CHCheryl M. Herrera
Cheryl M. Herrera
AAAngels Almenar-Queralt
Angels Almenar-Queralt
LGLawrence S. B. Goldstein
Lawrence S. B. Goldstein
The etiology of sporadic Alzheimer disease (AD) is largely unknown, although evidence implicates the pathological hallmark molecules amyloid beta (Aβ) and phosphorylated Tau. Work in animal models suggests that altered axonal transport caused by Kinesin-1 dysfunction perturbs levels of both Aβ and phosphorylated Tau in neural tissues, but the relevance of Kinesin-1 dependent functions to the human disease is unknown. To begin to address this issue, we generated human embryonic stem cells (hESC) expressing reduced levels of the kinesin light chain 1 (KLC1) Kinesin-1 subunit to use as a source of human neural cultures. Despite reduction of KLC1, undifferentiated hESC exhibited apparently normal colony morphology and pluripotency marker expression. Differentiated neural cultures derived from KLC1-suppressed hESC contained neural rosettes but further differentiation revealed obvious morphological changes along with reduced levels of microtubule-associated neural proteins, including Tau and less secreted Aβ, supporting the previously established connection between KLC1, Tau and Aβ. Intriguingly, KLC1-suppressed neural precursors (NPs), isolated using a cell surface marker signature known to identify cells that give rise to neurons and glia, unlike control cells, failed to proliferate. We suggest that KLC1 is required for normal human neural differentiation, ensuring proper metabolism of AD-associated molecules APP and Tau and for proliferation of NPs. Because impaired APP metabolism is linked to AD, this human cell culture model system will not only be a useful tool for understanding the role of KLC1 in regulating the production, transport and turnover of APP and Tau in neurons, but also in defining the essential function(s) of KLC1 in NPs and their progeny. This knowledge should have important implications for human neurodevelopmental and neurodegenerative diseases.

13 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
IGIvan Garcia-Bassets
Ivan Garcia-Bassets
GMGuoya Mo
Guoya Mo
YXYu Xia
Yu Xia
TWTsai-Chin Wu
Tsai-Chin Wu
IMImmanuel Mekuria
Immanuel Mekuria
ZCZhoutao Chen
Zhoutao Chen
Recent advances in barcoding technologies have significantly enhanced the scalability of single-cell genomic experiments. However, large-scale experiments are still rare due to high costs, complex logistics, and laborintensive procedures. To facilitate the routine application of the largest scalability, it is critical to simplify the production and use of barcoding reagents. Here, we introduce AmpliDrop, a technology that initiates the barcoding process using a pool of inexpensive single-copy barcodes and integrates barcode multiplicity generation with tagging of cellular content into a single reaction driven by DNA polymerase during library preparation. The barcoding reactions are compartmentalized using an electronic pipette or a robotic or standalone liquid handling system. These innovations eliminate the need for barcoded beads and complex combinatorial indexing workflows and provide flexibility for a wide range of scales and tube formats, as well as compatibility with automation. We show that AmpliDrop is capable of capturing transcriptomes and chromatin accessibility, and it can also be adapted for user-customized applications, including antibody-based protein detection, bacterial or viral DNA detection, and CRISPR perturbations without dual guide RNA-expression vectors. We validated AmpliDrop by investigating the influence of short-term static culturing on cell composition in human forebrain organoids, revealing metabolic reprogramming in lineage progenitors.

7 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AAAngels Almenar-Queralt
Angels Almenar-Queralt
IFIsabella R. Fernandes
Isabella R. Fernandes
JSJanaina Sena de Souza
Janaina Sena de Souza
ASAnju Singh
Anju Singh
XSXiwei Shan
Xiwei Shan
AMAlysson Muotri
Alysson Muotri
Intellectual disability (ID) and autism spectrum disorder (ASD) are neurodevelopmental conditions marked by lifelong impairments in cognitive, motor, and social functions. Hundreds of genetic variants have been linked to these disorders, including mutations in chromatin regulators such as the SET-domain-containing protein 5 (SETD5) gene. Most studies linking SETD5 loss-of-function to ASD/ID have focused primarily on neurons. However, while SETD5 is highly expressed in astrocytes, its role in glia cells remains poorly understood. Here, we examine how dysfunction of SETD5 in human-induced pluripotent stem cell (hiPSC)-derived astrocytes affects neuronal physiology. We show that SETD5-deficient astrocytes have increased levels of extracellular reactive oxygen species (ROS), glutamate, and interleukins-6 and 8 (IL-6 and (IL-8). Elevated astrocytic IL-6 exerts a non-cell autonomous harmful effect on healthy neurons. Using SETD5-deficient astrocytes as a screening platform, we identify the JAK/STAT pathway as an upstream regulator of abnormal IL-6 accumulation associated with SETD5 dysfunction. Accordingly, pharmacological inhibition of JAK-STAT signaling restores extracellular IL-6 to basal levels and partially rescues astrocyte morphology and neuronal deficits. Collectively, these findings highlight the JAK/STAT pathway as a key regulator of SETD5-mediated astrocytic function and suggest its potential as a therapeutic target for astrocytic-driven neuronal impairments in ASD and ID